Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
Yves Dauvilliers(Inserm), Jan Hedner(Sahlgrenska University Hospital), Dalma Seboek Kinter(Idorsia (Switzerland)), Ingo Fietze(Humboldt-Universität zu Berlin), Gary Zammit(Merck & Co., Inc., Rahway, NJ, USA (United States)), David Mayleben(Clinical Trial and Consulting), Scott Pain(Idorsia (Switzerland))
Cited by 145
Related Papers
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Short Sleep Duration as a Risk Factor for Hypertension
|Hypertension|2006|1.2k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k
Increased Incidence of Cardiovascular Disease in Middle-aged Men with Obstructive Sleep Apnea: A 7-Year Follow-up
|American Journal of Respiratory and Critical Care Medicine|2002|787